Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. | ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2015 | Founding Date 2017 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations KR HQ | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 141 | Employees 845% decrease |
Funding | ||
Total funding raised | Total funding raised $ 18.9m | Total funding raised $ 18m |
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company